Le Lézard
Classified in: Science and technology
Subjects: PER, SHM

Dye & Durham announces mailing of management information circular and board slate for December 19, 2023 annual general meeting of shareholders


TORONTO, Nov. 20, 2023 /CNW/ - Dye & Durham Limited ("Dye & Durham" or the "Company") (TSX: DND), one of the world's largest providers of cloud-based legal practice management software designed to make managing a law firm, organizing cases, and collaborating with clients easy, today announced that it has mailed its management information circular (the "Circular") and related meeting materials in respect of its upcoming annual general meting of shareholders, to be held on December 19, 2023 (the "Meeting"). In addition the Company announced the following individuals that are included in this year's slate of directors that will be proposed for election at the Meeting:

Both Ms. Moorehead and Mr. Brimm are very well respected in the Canadian business community, and the Company is very excited to have them as part of this year's slate of directors.

"Colleen and Peter are great additions to the Board with diverse experiences and expertise that will support our continued growth," said Matt Proud, CEO of Dye & Durham.

Ms. Moorehead is currently a Special Advisor to Osler, Hoskin & Harcourt LLP. Ms. Moorehead has extensive experience building successful companies and valuable brands. She had a long successful career in the financial services industry that spans over 35 years. While she began her career at Merrill Lynch and CIBC, Ms. Moorehead was a co-founder and President of E*TRADE Canada. Ms. Moorehead is Chair of the Board of Merrco Payments and past Chair of the Governance Committee and Board member of Solium Capital. She also participates in the early stage ecosystem through iNovia Capital Board of Advisors, Creative Destruction Lab Strategic Advisory Board and 111 Advisory Committee. Since 2003, Ms. Moorehead has been a founder and business director of The Judy Project, one of Canada's leading leadership forums, uniquely designed for executive women ascending to C-suite positions at the University of Toronto's Joseph Rotman School of Management. Ms. Moorehead is based in Toronto, Ontario, Canada.

Mr. Brimm has over 20 years of capital allocation, investing, and operating experience across multiple industries as a strategy and operations consultant, C-Suite executive, and investor. Mr. Brimm is currently the President of Envoy Holdings, a family office. Prior to this position, Mr. Brimm was the Executive Vice President of Strategy and Innovation for Shiplake Properties, a Toronto-based real estate firm. Previously to that, Mr. Brimm served as the Chief Growth Officer at Leap Tool Inc., where he helped build out the businesses capabilities and helped the business achieve significant revenue growth (qualifying for the Deloitte Fast50 for two consecutive years). He has also held various roles working as a portfolio manager for several leading hedge funds in the US and in Canada, including Relational Investors and West Face Capital Inc., among others. Mr. Brimm holds an MBA from the Stanford University Graduate School of Business with certificates in Global Management and Public Management and a B.A. cum laude in Business Economics from the University of California at Los Angeles. Mr. Brimm is a member of the CFA institute. Mr. Brimm is based in Toronto, Ontario, Canada.

Mr. Brimm was added to the slate following the printing of the Meeting materials, and therefore his biography is not included in the Circular sent to the Company's shareholders in connection with the Meeting. Other than in respect of the information included in this press release, the addition of Mr. Brimm would not result in any material changes to the Circular. Following the addition of Mr. Brimm to the slate, included below is certain updated information about the Company's director nominees.

Governance Element   

D&D Practice

Board Size

Seven nominee directors.

Board Independence

Six independent nominee directors.

Board Diversity

Two women nominee directors (29%) and one nominee director that self-identifies as a visible minority (14%) for a total of three directors (43%) that are nominated from underrepresented groups.

Not standing for re-election at the Meeting are Mario Di Pietro and Dave MacDonald, who have been directors since the initial public offering and contributed significantly to the development of the Company over the last three years.

Given the change to the slate, the Company expects to mail a new proxy to shareholders of record in respect of the Meeting, which will include Mr. Brimm as a director nominee. As indicated in the proxy and in accordance with applicable law, the securities represented by an applicable proxy will be voted as directed by the holder. However, if such a direction is not made in respect of any matter on the proxy, and the proxy appoints the Company's management nominees listed on the proxy as their proxyholder, the proxy will be voted as recommended by the Company's management. As such, all shares for which the Company's management nominees listed on the proxy are appointed as proxyholder, absent directions to the contrary, will be voted FOR Mr. Brimm's election.

About Dye & Durham

Dye & Durham Limited provides premier practice management solutions empowering legal professionals every day, delivers vital data insights to support critical corporate transactions and enables the essential payments infrastructure trusted by government and financial institutions. The company has operations in Canada, the United Kingdom, Ireland, Australia and South Africa.

Additional information can be found at www.dyedurham.com

Forward-Looking Statements

This press release may contain forward-looking information and forward-looking statements within the meaning of applicable securities laws, which reflects the Company's current expectations regarding future events, including with respect to the Company's Meeting and the election of the nominees at the Meeting. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance.

Specifically, statements regarding Dye & Durham's Meeting, the election of the slate of directors at the Meeting are forward-looking information. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under "Risk Factors" in the Company's most recent annual information form. If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking information. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.

No forward-looking statement is a guarantee of future events. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents Dye & Durham's expectations as of the date specified herein, and are subject to change after such date. However, the Company disclaims any intention or obligation or undertaking to update or revise any forward-looking information or to publicly announce the results of any revisions to any of those statements, whether as a result of new information, future events or otherwise, except as required under applicable securities laws. All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.

SOURCE Dye & Durham Limited


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: